2,729 STERIS plc $STE Shares Acquired by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC lifted its position in STERIS plc (NYSE:STE) by 20.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,158 shares of the medical equipment provider’s stock after acquiring an additional 2,729 shares during the quarter. Nisa Investment Advisors LLC’s holdings in STERIS were worth $3,393,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Western Wealth Management LLC purchased a new position in shares of STERIS during the 1st quarter worth about $25,000. Elevation Wealth Partners LLC grew its stake in shares of STERIS by 1,130.0% during the second quarter. Elevation Wealth Partners LLC now owns 123 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 113 shares during the last quarter. Meramec Financial Planners LLC bought a new position in shares of STERIS during the first quarter valued at approximately $33,000. Trust Co. of Vermont purchased a new stake in shares of STERIS in the second quarter worth approximately $41,000. Finally, Community Financial Services Group LLC raised its holdings in shares of STERIS by 50.0% in the third quarter. Community Financial Services Group LLC now owns 216 shares of the medical equipment provider’s stock worth $45,000 after buying an additional 72 shares during the period. 94.69% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at STERIS

In related news, Director Mohsen Sohi sold 4,058 shares of STERIS stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total value of $956,795.24. Following the completion of the sale, the director directly owned 24,305 shares in the company, valued at $5,730,632.90. The trade was a 14.31% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.12% of the stock is owned by insiders.

STERIS Stock Up 0.0%

Shares of NYSE:STE opened at $232.27 on Friday. The business’s 50 day moving average is $220.09 and its 200 day moving average is $218.16. The stock has a market cap of $22.65 billion, a P/E ratio of 28.39 and a beta of 0.92. STERIS plc has a 52-week low of $195.14 and a 52-week high of $269.44. The company has a quick ratio of 1.35, a current ratio of 1.91 and a debt-to-equity ratio of 0.23.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, August 5th. The medical equipment provider reported $2.59 earnings per share for the quarter, beating analysts’ consensus estimates of $2.49 by $0.10. STERIS had a return on equity of 14.34% and a net margin of 13.34%. The business had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.49 billion. During the same period in the previous year, the company posted $2.34 EPS. STERIS’s revenue was up 7.3% on a year-over-year basis. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. Sell-side analysts predict that STERIS plc will post 11.12 EPS for the current year.

STERIS Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Friday, September 4th were paid a dividend of $0.69 per share. This is an increase from STERIS’s previous quarterly dividend of $0.63. This represents a $2.76 annualized dividend and a dividend yield of 1.2%. The ex-dividend date was Friday, September 4th. STERIS’s payout ratio is 33.74%.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on STE shares. Piper Sandler reissued an “overweight” rating and set a $275.00 price target (up from $270.00) on shares of STERIS in a research note on Friday, August 7th. Wall Street Zen downgraded STERIS from a “strong-buy” rating to a “buy” rating in a research report on Sunday, October 11th. UBS Group cut their price objective on STERIS from $275.00 to $270.00 and set a “buy” rating on the stock in a research report on Friday, August 7th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of STERIS in a research note on Monday, August 24th. Three research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $271.33.

STERIS Profile

STERIS plc (NYSE: STE) provides products and services designed to support infection prevention, procedural care and the safe manufacture of healthcare and life sciences products. Its offerings include surgical equipment and operating-room solutions, sterilization and decontamination systems, endoscopy products, cleaning and disinfection technologies, and related consumable products.

The company also provides outsourced sterilization and laboratory services through its Applied Sterilization Technologies business.